宫颈癌与HPV感染的关系及患者术后肿瘤分期升级的影响因素分析-现代医学

宫颈癌与HPV感染的关系及患者术后肿瘤分期升级的影响因素分析

单位：1. 南京医科大学附属妇产医院妇科, 江苏南京 210004;
2. 南京医科大学附属明基医院妇产科, 江苏南京 210019

分类号：R737.33

出版年·卷·期（页码）：2022·50·第七期（884-888）

摘要：

目的：探讨宫颈癌与人类乳头瘤病毒（HPV）感染的关系及患者术后肿瘤分期升级的影响因素，为宫颈癌防治、临床管理及流行病学研究提供数据支持。方法：利用电子病历系统检索并收集2020年南京医科大学附属妇产医院收治的宫颈癌住院患者的临床资料，统计宫颈癌患者HPV感染情况、不同年龄组肿瘤分期、病理类型之间的差异以及术后分期升级的危险因素。结果：宫颈癌患者以早期鳞癌为主，其中HPV 16、18、53、33、52型为患者感染的主要亚型。不同年龄组患者肿瘤分期、病理类型之间差异均无统计学意义（P>0.05）；术后病理检查显示34例患者肿瘤分期升级，行多因素Logistic回归分析显示肌层浸润深度、脉管癌栓是其独立危险因素。结论：宫颈癌患者多有HPV感染病史，加强HPV筛查，有利于宫颈癌的防治；HPV相关宫颈癌治疗时应充分考虑肌层浸润深度、脉管癌栓的因素，选择最优治疗方案。

Objective: To analyse the relationship between cervical cancer and human papillomavirus(HPV) infection and the postoperative pathological staging escalation of HPV-associated cervical cancer, to provide scientific basis for cervical cancer prevention, clinical management and epidemiological research.Methods: Based on the diagnosis and treatment of cervical cancer cases in the Women's Hospital of Nanjing Medical University in 2020, clinical data of cervical cancer patients were retrieved and collected using electronic medical record system in 2020. The HPV infection, tumor stages in different age groups, differences between pathological types and risk factors for postoperative stage escalation of HPV-associated cervical cancer patients were analyzed. Results: Most of the patients with cervical cancer in our hospital were squamous cell carcinoma at early stage, mainly with HPV subtypes 16, 18, 53, 33, 52. There was no statistical difference in staging and pathological type among different age groups. According to postoperative pathological results, 34 patients were upgraded. Multifactor Logistic regression analysis showed that the depth of muscular invasion and vascular cancer embolus were independent risk factors. Conclusion: Most cervical cancer patients had a history of HPV infection. Enhancing HPV screening is beneficial to the prevention and treatment of cervical cancer. The depth of muscular invasion, vascular cancer thrombolysis should be fully considered in the optimal treatment of HPV associated cervical cancer.

参考文献：

[1] SIEGEL R L, MILLER K D, FUCHS H E, et al.Cancer statistics[J].CA Cancer J Clin, 2021, 71(1):7-33.
[2] JANSEN E, ZIELONKE N, GINI A, et al.Effect of organised cervical cancer screening on cervical cancer mortality in Europe:a systematic review[J].Eur J Cancer, 2020(127):207-223.
[3] PECORELLI S.Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J].Int J Gynecol Obstet, 2009, 105(2):103-104.
[4] BHATLA N, DENNY L.FIGO cancer report 2018[J].Int J Gynaecol Obstet, 2018, 143(S2):2-3.
[5] 刘萍.中国大陆13年宫颈癌临床流行病学大数据评价[J].中国实用妇科与产科杂志, 2018, 34(1):41-45.
[6] 王一琳, 吴霞, 狄文.宫颈腺癌与宫颈鳞癌的临床特征分析[J].实用妇产科杂志, 2015, 31(2):150-152.
[7] 周晖, 刘昀昀, 罗铭, 等.《2021 NCCN子宫颈癌临床实践指南(第1版)》解读[J].中国实用妇科与产科杂志, 2020, 36(11):1098-1104.
[8] MACDONALD M, CROSSLEY J, ELLIS K, et al.Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology[J].Cytopathology, 2018, 29(2):133-142.
[9] HU Z, MA D.The precision prevention and therapy of HPV-related cervical cancer:new concepts and clinical implications[J].Cancer Med, 2018, 7(10):5217-5236.
[10] 张靖, 高波, 康赟, 等.中国女性宫颈人乳头瘤病毒感染型别分布区域性特征的Meta分析[J].中华微生物学和免疫学杂志, 2014, 34(12):913-920.
[11] 赵昀, 魏丽惠.CSCCP关于中国宫颈癌筛查及异常管理相关问题专家共识解读[J].实用妇产科杂志, 2018, 34(2):101-104.
[12] RAMIREZ P, FRUMOVITZ M, PAREJA R, et al.Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J].New Engl J Med, 2018, 379(20):1895-1904.
[13] 梁磊磊, 曾嘉, 姚洪文, 等.ⅠB期宫颈癌淋巴结转移临床病理因素及预后分析[J].中华转移性肿瘤杂志, 2020, 3(4):274-277.
[14] BHATLA N, BEREK J S, CUELLO FREDES M, et al.Revised FIGO staging for carcinoma of the cervix uteri[J].Int J Gynaecol Obstet, 2019, 145(1):129-135.
[15] RAN C, SUN J, QU Y, et al.Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer[J].World J Surg Oncol, 2021, 19(1):343.
[16] 黄碧芬, 郑建清.PET/CT对比MRI用于诊断宫颈癌盆腔淋巴结转移价值的Meta分析[J].黑龙江医学, 2022, 46(3):306-308, 312.
[17] 王彤, 孙洪赞, 张军.对比PET-CT与MRI对宫颈癌淋巴结转移诊断价值的Meta分析[J].现代医学, 2020, 48(6):6.
[18] ANNEDE P, GOUY S, HAIE-MEDER C, et al.Place of radiotherapy and surgery in the treatment of cervical cancer patients[J].Cancer Radiother, 2019, 23(6-7):737-744.
[19] STOLNICU S, HOANG L, SOSLOW R A.Recent advances in invasive adenocarcinoma of the cervix[J].Virchows Arch, 2019, 475(5):537-549.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录